Stemline Therapeutics Inc (STML) Receives Consensus Rating of “Buy” from Brokerages

Retrieved on: 2018-09-05 18:07:30

Tags for this article:

Click the tags to see associated articles and topics

Stemline Therapeutics Inc (STML) Receives Consensus Rating of “Buy” from Brokerages. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc purchased a new stake in Stemline Therapeutics in the 1st quarter worth $193,000. DekaBank Deutsche Girozentrale ...</div>

Article found on:

View Original Article